Santiago Oviedo Rouco

ORCID: 0000-0001-9140-1755
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • Photoreceptor and optogenetics research
  • Photosynthetic Processes and Mechanisms
  • Vaccine Coverage and Hesitancy
  • COVID-19 epidemiological studies
  • Spectroscopy and Quantum Chemical Studies
  • COVID-19 Clinical Research Studies
  • Viral Infections and Vectors
  • Electrochemical sensors and biosensors
  • Mosquito-borne diseases and control
  • Hemoglobin structure and function
  • Animal Virus Infections Studies
  • RNA regulation and disease
  • bioluminescence and chemiluminescence research
  • Viral Infections and Immunology Research
  • Protein Interaction Studies and Fluorescence Analysis
  • COVID-19 Impact on Reproduction
  • Malaria Research and Control
  • Viral gastroenteritis research and epidemiology
  • Electrochemical Analysis and Applications
  • Immunotherapy and Immune Responses

Consejo Nacional de Investigaciones Científicas y Técnicas
2021-2024

Fundación Instituto Leloir
2021-2024

Fundación Ciencias Exactas y Naturales
2015-2021

University of Buenos Aires
2015-2021

Instituto de Química y Fisicoquímica Biológicas
2021

Institute of Astronomy and Space Physics
2015-2019

Massive vaccination offers great promise for halting the global COVID-19 pandemic. However, limited supply and uneven vaccine distribution create an urgent need to optimize strategies. We evaluate SARS-CoV-2-specific antibody responses after Sputnik V of healthcare workers in Argentina, measuring IgG anti-spike titers neutralizing capacity one two doses a cohort naive or previously infected volunteers. By 21 days receiving first dose vaccine, 94% participants develop spike-specific...

10.1016/j.xcrm.2021.100359 article EN cc-by-nc-nd Cell Reports Medicine 2021-07-09

Heterologous vaccination against coronavirus disease 2019 (COVID-19) provides a rational strategy to rapidly increase coverage in many regions of the world. Although data regarding messenger RNA (mRNA) and ChAdOx1 vaccine combinations are available, there is limited information about combination these platforms with other vaccines widely used developing countries, such as BBIBP-CorV Sputnik V. Here, we assess immunogenicity reactogenicity 15 1,314 participants. We evaluate immunoglobulin G...

10.1016/j.xcrm.2022.100706 article EN cc-by-nc-nd Cell Reports Medicine 2022-08-01

We report a resonance Raman and UV-vis characterization of the active site structure oxidatively modified forms cytochrome c (Cyt-c) free in solution complexes with cardiolipin (CL). The studied post-translational modifications Cyt-c include methionine sulfoxidation tyrosine nitration, which lead to altered heme axial ligation increased peroxidase activity respect those wild-type protein. In spite structural differences between protein variants solution, binding CL liposomes induces all...

10.1021/acs.biochem.5b00922 article EN Biochemistry 2015-12-01

Vaccines have been produced in record time for SARS-CoV-2, offering the possibility of halting global pandemic. However, inequalities vaccine accessibility different regions world create a need to increase international cooperation.

10.1128/mbio.03442-21 article EN mBio 2022-01-25

Dengue virus (DENV) is the most important human transmitted by mosquitos. pathogenesis characterized a large induction of proinflammatory cytokines. This cytokine varies among four DENV serotypes (DENV1 to 4) and poses challenge for live vaccine design. Here, we identify viral mechanism limit NF-κB activation secretion protein NS5. Using proteomics, found that NS5 binds degrades host ERC1 antagonize activation, secretion, reduce cell migration. We degradation involves unique properties...

10.1073/pnas.2220005120 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2023-05-30

Abstract Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that causes severe outbreaks in human populations. ZIKV infection leads to the accumulation of small non-coding viral RNAs (known as sfRNAs) are crucial for evasion antiviral responses and pathogenesis. However, mechanistic understanding how sfRNAs function remains incomplete. Here, we use recombinant ZIKVs ribosome profiling infected cells show block translation genes. Mechanistically, demonstrate specific RNA structures...

10.1093/nar/gkae507 article EN cc-by-nc Nucleic Acids Research 2024-06-05

Background Recent studies have shown the presence of SARS-CoV-2-specific antibodies in milk breastfeeding mothers vaccinated with mRNA and convalescent. However, limited information is available lactating women receiving other vaccine platforms used developing countries, such as inactivated SARS-CoV-2 BBIBP-CorV (Sinopharm) non-replicating adenovirus vaccines Sputnik V (Gamaleya Institute) ChAdOx1-S (Oxford AstraZeneca). Methods Here, we evaluated anti-SARS-CoV-2 IgG IgA levels both serum...

10.3389/fimmu.2022.909995 article EN cc-by Frontiers in Immunology 2022-10-03

ABSTRACT Recent studies have shown a temporal increase in the neutralizing antibody potency and breadth to SARS-CoV-2 variants coronavirus disease 2019 (COVID-19) convalescent individuals. Here, we examined longitudinal responses viral capacity B.1 lineage virus (Wuhan related), of concern (VOCs: Alpha, Beta, Gamma, Delta) local variant interest (VOI: Lambda) volunteers receiving Sputnik V vaccine Argentina. A collection 472 serum samples obtained between January September 2021 was used. The...

10.1101/2021.08.22.21262186 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-08-25
Coming Soon ...